1. Vascular Biogenics Ltd. (11 from 46 patents)

2. Mor Research Applications Ltd. (4 from 101 patents)

3. The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center (1 from 48 patents)

1. 12358973 - Transthyretin antibodies and uses thereof

2. 12351629 - TREM2 antibodies and uses thereof

3. 12006357 - Transthyretin antibodies and uses thereof

4. 11512125 - Antibodies for the treatment of synucleinopathies and neuroinflammation

5. 9067989 - Eotaxin-2 (CCL24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders

6. 8563534 - Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

7. 8501715 - Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

8. 8158611 - Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

9. 7973023 - Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

10. 7902176 - Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

11. 7893291 - Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

12. 7625882 - Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

13. 7504388 - Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

14. 7279459 - Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis

15. 7186704 - Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis